Decision of the EEA Joint Committee No 195/2025 of 19 September 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/4]
Date: 2025-09-19
Institutions: EEA Joint Committee
Subjects: European Economic Area, chemical salt, grape, leguminous vegetable, market approval, microorganism, plant health control, plant health product, revision of an agreement, seed




L_202600004EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2026/4


15.1.2026







            DECISION OF THE EEA JOINT COMMITTEE No 195/2025
of 19 September 2025
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/4]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2025/96 of 21 January 2025 approving the basic substance Vitis vinifera L. seed extract (grape seed extract) in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2025/99 of 21 January 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances Aureobasidium pullulans (strains DSM 14940 and DSM 14941), Bacillus amyloliquefaciens subsp. plantarum D747, benalaxyl-M, cyprodinil, dichlorprop-P, formetanate, fosetyl, halosulfuron-methyl, imazamox, milbemectin, phenmedipham, pirimicarb, Pseudomonas sp. strain DSMZ 13134, pyrimethanil, pyriofenone, pyroxsulam, spinosad, sulphur, Trichoderma harzianum Rifai strains T-22 and ITEM 908, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T-25 and TV-1, Trichoderma atroviride (formerly T. harzianum) strain T11, Trichoderma gamsii (formerly T. viride) strain ICC080, triticonazole and ziram (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2025/102 of 21 January 2025 approving the active substance Pythium oligandrum B301 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2025/103 of 22 January 2025 approving the active substance Betabaculovirus phoperculellae as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) 2025/106 of 22 January 2025 approving the active substance Bacillus subtilis strain RTI477 as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) 2025/109 of 22 January 2025 approving the active substance Bacillus velezensis strain RTI301 as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (6) is to be incorporated into the EEA Agreement.












(7)


Commission Implementing Regulation (EU) 2025/119 of 24 January 2025 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the low-risk active substance aqueous extract from the germinated seeds of sweet Lupinus albus (7) is to be incorporated into the EEA Agreement.












(8)


Commission Implementing Regulation (EU) 2025/150 of 29 January 2025 renewing the approval of the active substance mepiquat chloride in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (8) is to be incorporated into the EEA Agreement.












(9)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement is amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32025 R 0096: Commission Implementing Regulation (EU) 2025/96 of 21 January 2025 (OJ L, 2025/96, 22.1.2025),










—



32025 R 0099: Commission Implementing Regulation (EU) 2025/99 of 21 January 2025 (OJ L, 2025/99, 22.1.2025),










—



32025 R 0102: Commission Implementing Regulation (EU) 2025/102 of 21 January 2025 (OJ L, 2025/102, 22.1.2025),










—



32025 R 0103: Commission Implementing Regulation (EU) 2025/103 of 22 January 2025 (OJ L, 2025/103, 23.1.2025),










—



32025 R 0106: Commission Implementing Regulation (EU) 2025/106 of 22 January 2025 (OJ L, 2025/106, 23.1.2025),










—



32025 R 0109: Commission Implementing Regulation (EU) 2025/109 of 22 January 2025 (OJ L, 2025/109, 23.1.2025),










—



32025 R 0119: Commission Implementing Regulation (EU) 2025/119 of 24 January 2025 (OJ L, 2025/119, 27.1.2025),










—



32025 R 0150: Commission Implementing Regulation (EU) 2025/150 of 29 January 2025 (OJ L, 2025/150, 30.1.2025).’














2.


The following points are inserted after point 13zzzzzzzzzzzzzzzb (Commission Implementing Regulation (EU) 2024/2878):






‘13zzzzzzzzzzzzzzzc.



32025 R 0096: Commission Implementing Regulation (EU) 2025/96 of 21 January 2025 approving the basic substance Vitis vinifera L. seed extract (grape seed extract) in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2025/96, 22.1.2025).










13zzzzzzzzzzzzzzzd.



32025 R 0102: Commission Implementing Regulation (EU) 2025/102 of 21 January 2025 approving the active substance Pythium oligandrum B301 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2025/102, 22.1.2025).










13zzzzzzzzzzzzzzze.



32025 R 0103: Commission Implementing Regulation (EU) 2025/103 of 22 January 2025 approving the active substance Betabaculovirus phoperculellae as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2025/103, 23.1.2025).










13zzzzzzzzzzzzzzzf.



32025 R 0106: Commission Implementing Regulation (EU) 2025/106 of 22 January 2025 approving the active substance Bacillus subtilis strain RTI477 as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2025/106, 23.1.2025).










13zzzzzzzzzzzzzzzg.



32025 R 0109: Commission Implementing Regulation (EU) 2025/109 of 22 January 2025 approving the active substance Bacillus velezensis strain RTI301 as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2025/109, 23.1.2025).










13zzzzzzzzzzzzzzzh.



32025 R 0150: Commission Implementing Regulation (EU) 2025/150 of 29 January 2025 renewing the approval of the active substance mepiquat chloride in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2025/150, 30.1.2025).’










Article 2
The texts of Implementing Regulations (EU) 2025/96, (EU) 2025/99, (EU) 2025/102, (EU) 2025/103, (EU) 2025/106, (EU) 2025/109, (EU) 2025/119 and (EU) 2025/150 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 20 September 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 19 September 2025.


For the EEA Joint Committee


The President

Stefán Haukur JÓHANNESSON
            





(1)  
            OJ L, 2025/96, 22.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/96/oj.

(2)  
            OJ L, 2025/99, 22.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/99/oj.

(3)  
            OJ L, 2025/102, 22.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/102/oj.

(4)  
            OJ L, 2025/103, 23.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/103/oj.

(5)  
            OJ L, 2025/106, 23.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/106/oj.

(6)  
            OJ L, 2025/109, 23.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/109/oj.

(7)  
            OJ L, 2025/119, 27.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/119/oj.

(8)  
            OJ L, 2025/150, 30.1.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/150/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2026/4/oj
ISSN 1977-0677 (electronic edition)